Skip to main content
Edwards Lifesciences Logo
Edwards Lifesciences Logo

Mitral and tricuspid valve repair and recovery

What you can expect from transcatheter valve repair to treat your leaking valve

Dr consulting with patient
Dr consulting with patient
Dr consulting with patient

What to expect from the procedure

Transcatheter mitral valve repair (TMVr) and transcatheter tricuspid valve repair (TTVr) involve implanting a device through an incision near your groin using a flexible tube called a catheter. The device is used to repair your leaking mitral or tricuspid heart valve.1

Dr showing patient chart
Dr showing patient chart
Dr showing patient chart

Before the procedure

Your interventional cardiologist will give you instructions on preparing for the procedure. This may include instructions to stop or start taking certain medications.

Dorothy’s transcatheter valve repair story

The results were amazing. I would say that I live a better-than-normal life for an 85-year-old woman.

-

Dorothy, PASCAL Precision system patient

‌
‌

Frequently asked questions

Get to know the PASCAL Precision system

Learn about each valve repair procedure and how the PASCAL Precision system can treat mitral or tricuspid regurgitation.

DR consulting patient
DR consulting patient
DR consulting patient
Read about the device
DR consulting patient
DR consulting patient
DR consulting patient

Download resources

Get answers to your questions about mitral regurgitation, tricuspid regurgitation and treatment in these downloadable PDFs.

Mitral regurgitation brochureTricuspid regurgitation brochure
Brochures
Brochures
Brochures

References

  1. Edwards Lifesciences. Edwards PASCAL Precision Transcatheter Valve Repair System. Instructions for Use. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf22/P220003D.pdf [Accessed 27 April 2023].
  2. Szerlip M, et al. 2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. JACC Cardiovasc Interv. 2021 Jul 26;14(14):1538-1548. Erratum in: JACC Cardiovasc Interv. 2022 Jul 11;15(13):1395.
  3. Lim DS, et al. Randomized comparison of transcatheter edge-to-edge repair for degenerative mitral regurgitation in prohibitive surgical risk patients. J Am Coll Cardiol Intv. 2022;15:2523-36.
  4. Kodali S, et al. 1-Year outcomes of transcatheter tricuspid valve repair. J Am Coll Cardiol. 2023 May 9;81(18):1766-1776. doi: 10.1016/j.jacc.2023.02.049.
  5. Kitamura M, et al. 12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Catheter Cardiovasc Interv. 2021 May 1;97(6):1281-1289.
Medical device for professional use.

Medical device for professional use.

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards, Edwards Lifesciences, the stylized E logo, CLASP, Edwards PASCAL, Edwards PASCAL Precision, PASCAL, and PASCAL Precision are trademarks or service marks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2023 Edwards Lifesciences Corporation. All rights reserved. PP--EU-5802 v1.0

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com